Pheochromocytoma
📧 Sign up to get email alerts when something new happens for Pheochromocytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy [Phase 4]
A Phase 4 randomized trial comparing posterior retroperitoneoscopic adrenalectomy with lateral laparoscopic adrenalectomy for adrenal tumors…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [Phase 2]
Phase 2 trial update evaluating the combination of chemotherapy and tamoxifen in patients with solid tumors has completed.
-
CLINICAL_TRIALS research · 2013-06-10Clinical Trial Update: Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
This trial update describes content validation of quality-of-life and symptom questionnaires for patients with pheochromocytoma and paragang…
-
FDA approval · 2013-03-20FDA Approved: ADREVIEW — Supplemental Application (Medi-Physics Inc.)
FDA approved a supplemental application for ADREVIEW (Iobenguane I-123) from Medi-Physics Inc. to update its labeling/indications as a radio…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]
Phase II, multi-histology trial of fostamatinib disodium (R935788) in advanced colorectal, non-small cell lung, head and neck, hepatocellula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial evaluating internal radiation therapy for liver metastases from neuroendocrine tumors was terminated.
-
FDA approval · 2012-01-27FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for propranolol hydrochloride from Ipca Laboratories Limited, finalizing a regulatory update for the…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid [Phase 1]
Phase 1 clinical trial of Ultratrace iobenguane I-131 in patients with malignant pheochromocytoma, paraganglioma, or metastatic carcinoid ha…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors [Phase 3]
This is a Phase 3 clinical trial update evaluating 123I‑MIBG scintigraphy for evaluating patients with suspected neuroendocrine tumors, incl…
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
Completed clinical trial evaluating the use of I-123-labeled meta-iodobenzylguanidine (MIBG) for imaging neuroblastoma and pheochromocytoma.
-
FDA approval · 2008-09-19FDA Approved: ADREVIEW — Original Application (Medi-Physics Inc.)
FDA approved the original application for ADREVIEW (IOBENGUANE I-123) from Medi-Physics Inc., a radiopharmaceutical imaging agent for locati…
-
FDA approval · 2008-09-10FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for propranolol hydrochloride from Hikma Pharmaceuticals USA Inc., indicating regulatory approval of…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Diagnosis and Treatment of Pheochromocytoma
A National Heart, Lung, and Blood Institute-supported trial on the diagnosis and treatment of pheochromocytoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Blood Sampling for Neurochemical and Genetic Testing
This clinical trial update reports completion of blood sampling for neurochemical and genetic testing under NINDS. The study enrolled indivi…
-
FDA approval · 2007-06-21FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for propranolol hydrochloride (generic) from Hikma Pharmaceuticals USA Inc., indicating an approval …
-
FDA approval · 2007-01-03FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INDERAL LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc. This action au…